Robert Malcolm to Humans
This is a "connection" page, showing publications Robert Malcolm has written about Humans.
Connection Strength
0.699
-
Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate. J Clin Psychopharmacol. 2015 Aug; 35(4):464-7.
Score: 0.019
-
A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
Score: 0.016
-
Effects of intravenous nicotine on prepulse inhibition in smokers and non-smokers: relationship with familial smoking. Psychopharmacology (Berl). 2013 Sep; 229(2):285-94.
Score: 0.016
-
Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans. Drug Metab Dispos. 2013 Jan; 41(1):197-205.
Score: 0.016
-
Physician acceptance of academic detailing for schizophrenia among South Carolina Medicaid providers. J S C Med Assoc. 2012 Aug; 108(4):100-2.
Score: 0.016
-
The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity. Addict Behav. 2011 Dec; 36(12):1223-7.
Score: 0.014
-
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012 Feb; 100(4):801-10.
Score: 0.014
-
Disulfiram: an old therapeutic with new applications. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):5-12.
Score: 0.013
-
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
Score: 0.013
-
Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
Score: 0.012
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.012
-
The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf. 2008 Jul; 7(4):459-72.
Score: 0.012
-
A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study. Subst Abuse Treat Prev Policy. 2008 Jun 03; 3:13.
Score: 0.012
-
Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
Score: 0.011
-
Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007 Feb 15; 3(1):24-32.
Score: 0.011
-
An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
Score: 0.010
-
Risk factors for delirium tremens: a retrospective chart review. Am J Addict. 2006 May-Jun; 15(3):213-9.
Score: 0.010
-
Randomization in substance abuse clinical trials. Subst Abuse Treat Prev Policy. 2006 Feb 06; 1:6.
Score: 0.010
-
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse. 2006; 32(4):577-87.
Score: 0.010
-
A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal. J Psychoactive Drugs. 2005 Dec; 37(4):409-14.
Score: 0.010
-
A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
Score: 0.009
-
Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Alcohol Clin Exp Res. 2004 Feb; 28(2):295-301.
Score: 0.009
-
Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
Score: 0.008
-
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans. J Clin Psychiatry. 2023 Mar 08; 84(2).
Score: 0.008
-
GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry. 2003; 64 Suppl 3:36-40.
Score: 0.008
-
New anticonvulsants: a review of applications for the management of substance abuse disorders. Ann Clin Psychiatry. 2002 Dec; 14(4):233-45.
Score: 0.008
-
Amlodipine reduces blood pressure and headache frequency in cocaine-dependent outpatients. J Psychoactive Drugs. 2002 Oct-Dec; 34(4):415-9.
Score: 0.008
-
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50.
Score: 0.007
-
Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life. Transl Behav Med. 2021 12 14; 11(12):2091-2098.
Score: 0.007
-
Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2021 11 02; 10(21):e022930.
Score: 0.007
-
Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
Score: 0.007
-
Impact of Fatty Acid Supplementation on Cognitive Performance among United States (US) Military Officers: The Ranger Resilience and Improved Performance on Phospholipid-Bound Omega-3's (RRIPP-3) Study. Nutrients. 2021 May 29; 13(6).
Score: 0.007
-
Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
Score: 0.007
-
Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001; 10(s1):s16-s23.
Score: 0.007
-
New developments in the pharmacotherapy of alcohol dependence. Am J Addict. 2001; 10(s1):s3-s15.
Score: 0.007
-
Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis. 2001; 20(1):81-92.
Score: 0.007
-
Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64.
Score: 0.007
-
A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8.
Score: 0.007
-
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
Score: 0.007
-
Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
Score: 0.007
-
Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale. Alcohol. 2000 Feb; 20(2):181-5.
Score: 0.007
-
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
Score: 0.007
-
Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena. Am J Drug Alcohol Abuse. 1999 Nov; 25(4):629-37.
Score: 0.006
-
Amlodipine treatment of cocaine dependence. J Psychoactive Drugs. 1999 Apr-Jun; 31(2):117-20.
Score: 0.006
-
Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol. 1999 Jan; 17(1):7-11.
Score: 0.006
-
Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention. Obesity (Silver Spring). 2017 12; 25(12):2062-2067.
Score: 0.006
-
Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
Score: 0.006
-
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol. 2017 Aug; 37(4):419-428.
Score: 0.005
-
Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
Score: 0.005
-
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 2017 Mar 01; 172:9-13.
Score: 0.005
-
A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
Score: 0.005
-
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
Score: 0.005
-
Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
Score: 0.005
-
Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. Am J Drug Alcohol Abuse. 2016 05; 42(3):333-40.
Score: 0.005
-
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
Score: 0.005
-
Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995 Jul; 39(1):69-71.
Score: 0.005
-
Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients. Int J Psychiatry Med. 2015; 49(4):279-95.
Score: 0.005
-
Emotional eating, marital status and history of physical abuse predict 2-year weight loss in weight loss surgery patients. Eat Behav. 2014 Dec; 15(4):619-24.
Score: 0.004
-
Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain. Pain Med. 2014 Aug; 15(8):1359-64.
Score: 0.004
-
Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
Score: 0.004
-
Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
Score: 0.004
-
Types of benzodiazepines abused by chemically dependent inpatients. J Psychoactive Drugs. 1993 Oct-Dec; 25(4):315-9.
Score: 0.004
-
Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
Score: 0.004
-
Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study. Drug Alcohol Depend. 2013 Dec 01; 133(2):641-6.
Score: 0.004
-
Pharmacotherapy of obesity: clinical treatments and considerations. Am J Med Sci. 2013 Apr; 345(4):284-288.
Score: 0.004
-
Chronic pain among liver transplant candidates. Prog Transplant. 2012 Dec; 22(4):379-84.
Score: 0.004
-
A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res. 1992 Dec; 16(6):1007-13.
Score: 0.004
-
Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample. Am J Addict. 2012 Sep-Oct; 21(5):435-44.
Score: 0.004
-
Disulfiram and alcoholism treatment. Am Fam Physician. 1992 Apr; 45(4):1544, 1547-8.
Score: 0.004
-
Excess health care service utilization and costs associated with underrecognition of psychiatric comorbidity in a medical/surgical inpatient setting. Qual Manag Health Care. 2011 Apr-Jun; 20(2):98-102.
Score: 0.004
-
Symptoms of anxiety in inpatient alcoholics with and without DSM-III-R anxiety diagnoses. Alcohol Clin Exp Res. 1991 Feb; 15(1):102-5.
Score: 0.003
-
Profiles of hospitalized benzodiazepine abusers. J Psychoactive Drugs. 1991 Jan-Mar; 23(1):71-2.
Score: 0.003
-
Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry. 1991 Jan; 52(1):39-40.
Score: 0.003
-
Distinctive characteristics of methamphetamine users presenting at public clinics: steep rise in South Carolina, United States, 2000-2005. Drug Alcohol Depend. 2011 May 01; 115(1-2):9-15.
Score: 0.003
-
A piece of my mind. Little battles. JAMA. 1990 Jan 05; 263(1):90.
Score: 0.003
-
Modafinil: an anti-relapse medication. Neuropsychopharmacology. 2010 Jan; 35(1):343-4.
Score: 0.003
-
Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):119-25.
Score: 0.003
-
Depression and bulimia: the link between depression and bulimic cognitions. J Abnorm Psychol. 1989 Aug; 98(3):322-5.
Score: 0.003
-
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
Score: 0.003
-
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21.
Score: 0.003
-
Abnormalities of the septum pellucidum in schizophrenia. J Neuropsychiatry Clin Neurosci. 1989; 1(4):385-90.
Score: 0.003
-
Application of behavioral principles in the management of suffocation phobia: a case study of chronic respiratory failure. Int J Psychiatry Med. 1989; 19(3):281-9.
Score: 0.003
-
More on idiosyncratic reaction to naltrexone. Am J Psychiatry. 1989 Jan; 146(1):124-5.
Score: 0.003
-
The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009 May 15; 65(10):841-5.
Score: 0.003
-
Differences between adult non-drug users versus alcohol, cocaine and concurrent alcohol and cocaine problem users. Addict Behav. 2009 Mar; 34(3):323-6.
Score: 0.003
-
Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond). 2009 Jan; 33(1):144-50.
Score: 0.003
-
Idiosyncratic reaction to naltrexone augmented by thioridazine. Am J Psychiatry. 1988 Jun; 145(6):773-4.
Score: 0.003
-
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet. 2008 Jun; 82(6):1241-8.
Score: 0.003
-
Update on the management of obesity. South Med J. 1988 May; 81(5):632-9.
Score: 0.003
-
Adolescents with insomnia and substance abuse: consequences and comorbidities. J Psychiatr Pract. 2008 May; 14(3):146-53.
Score: 0.003
-
Failure of sleep deprivation to prolong seizures in ECT. Am J Psychiatry. 1988 Apr; 145(4):530.
Score: 0.003
-
Acquired immune deficiency syndrome: psychological impact on health personnel. J Nerv Ment Dis. 1987 Aug; 175(8):496-9.
Score: 0.003
-
Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
Score: 0.003
-
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry. 2007 Jun; 164(6):979.
Score: 0.003
-
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2007 Mar; 81(3):346-53.
Score: 0.003
-
Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men. Nicotine Tob Res. 2007 Jan; 9(1):65-82.
Score: 0.003
-
Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict Behav. 2007 Jul; 32(7):1433-40.
Score: 0.003
-
Silver acetate gum as a deterrent to smoking. Chest. 1986 Jul; 90(1):107-11.
Score: 0.003
-
An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav. 2006 Sep; 31(9):1628-49.
Score: 0.002
-
Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers. J Clin Pharmacol. 2006 Feb; 46(2):164-71.
Score: 0.002
-
Facial electromyography for the diagnosis of depression. Am J Psychiatry. 1986 Jan; 143(1):123-4.
Score: 0.002
-
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
Score: 0.002
-
A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
Score: 0.002
-
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet. 2005; 44(7):753-65.
Score: 0.002
-
Insomnia and its treatment. When are hypnotics justified? Postgrad Med. 1984 Jul; 76(1):83-90.
Score: 0.002
-
Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict. 2004 May-Jun; 13(3):321-3.
Score: 0.002
-
Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. Ann Clin Psychiatry. 2004 Apr-Jun; 16(2):101-9.
Score: 0.002
-
Family-focused smoking cessation:enhanced efficacy by the addition of partner support and group therapy. Subst Abus. 2004 Mar; 25(1):37-41.
Score: 0.002
-
Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med. 2004 Feb 01; 116(3):151-7.
Score: 0.002
-
Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res. 2004 Feb; 28(2):233-46.
Score: 0.002
-
Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies. Ther Drug Monit. 2003 Apr; 25(2):197-202.
Score: 0.002
-
Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
Score: 0.002
-
Gabapentin for misuse of homemade nicotine nasal spray. Am J Psychiatry. 2001 Mar; 158(3):498.
Score: 0.002
-
Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
Score: 0.002
-
Taste hedonics and thresholds in obesity. Int J Obes. 1980; 4(3):203-12.
Score: 0.002
-
Behavioral techniques in the psychological rehabilitation of burn patients. Int J Psychiatry Med. 1980-1981; 10(2):145-50.
Score: 0.002
-
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64.
Score: 0.002
-
Pancytopenia associated with varicella. Br J Clin Pract. 1979 Oct; 33(10):299-300.
Score: 0.002
-
Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84.
Score: 0.002
-
Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998 Nov; 155(11):1632.
Score: 0.001
-
The role of weight control as a motivation for cocaine abuse. Addict Behav. 1998 Mar-Apr; 23(2):201-7.
Score: 0.001
-
Behavior modification in the management of obesity. J S C Med Assoc. 1977 May; 73(5):197-9.
Score: 0.001
-
Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997; 6(2):117-23.
Score: 0.001
-
Phencyclidine toxicity: ""animal tranquilizer'' reactions. Dis Nerv Syst. 1976 Oct; 37(10):590-2.
Score: 0.001
-
Naltrexone treatment of self-injurious thoughts and behaviors. J Nerv Ment Dis. 1996 Mar; 184(3):192-5.
Score: 0.001
-
Current views on the management of obesity. South Med J. 1976 Feb; 69(2):138-40.
Score: 0.001
-
Alcohol treatment: measurement of effectiveness by global outcome. Soc Work Health Care. 1996; 23(3):57-71.
Score: 0.001
-
Treatment of panic disorder and comorbid substance abuse with divalproex sodium. Am J Psychiatry. 1994 Oct; 151(10):1521.
Score: 0.001
-
Dimenhydrinate (Dramamine) abuse: hallucinogenic experiences with a proprietary antihistamine. Am J Psychiatry. 1972 Feb; 128(8):1012-3.
Score: 0.001
-
Cocaine-induced psychosis. J Clin Psychiatry. 1991 Dec; 52(12):509-12.
Score: 0.001
-
Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse. 1991; 17(4):389-97.
Score: 0.001
-
Abuse of caffeine in substance abusers. J Clin Psychiatry. 1988 Nov; 49(11):457.
Score: 0.001
-
Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14.
Score: 0.001
-
Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr. 1986; 67:66-72.
Score: 0.001
-
Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983 Sep; 14(3):251-6.
Score: 0.001
-
Psychosocial and developmental factors in failure to thrive: one- to three- year follow-up. J Dev Behav Pediatr. 1981 Sep; 2(3):112-4.
Score: 0.000
-
Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
Score: 0.000
-
Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
Score: 0.000
-
Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation. Addict Behav. 1979; 4(2):167-77.
Score: 0.000
-
The problem patient as perceived by family physicians. J Fam Pract. 1977 Sep; 5(3):361-4.
Score: 0.000
-
Behavioral treatment of obesity. Limitations and results with the chronically obese. JAMA. 1977 Jun 27; 237(26):2829-31.
Score: 0.000